Globus Medical (GMED) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Globus Medical Reports First Quarter 2016 Results
May 3, 2016 4:16 PM EDTAUDUBON, Pa., May 03, 2016 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the first quarter ended March 31, 2016.
Worldwide sales increased 5.8% as reported to $139.3 million, or 6.2% on a constant currency basisFirst quarter net income increased 13.6% to $28.0 millionFully diluted earnings per share (EPS) increased 13.2% to $0.29Non-GAAP Adjusted EBITDA was 38.2% of salesCompany reiterates 2016 guidance for sales of $583 million and EPS of $1.20David Paul, Chairman and CEO said, First quarter sales were $139.3 million, a year-over-year increase of... More
